8:03am ET
Investing
Wednesday’s Premarket: 5 S&P 500 Winners, 5 Losers
Here are the S&P 500 stocks moving up or down the most in Wednesday's premarket trading session.
Companies
/Healthcare
Merck & Co Inc
$147.15
▲ $2.24 (+1.55%) today
Markets closed · 8:04am ET
MRK Coverage
Page 14
6:30am ET
10:12am ET
Investing
Meet the Preliminary Dogs of the Dow for 2022
Here is a look at the stocks currently in the running to be Dogs of the Dow for 2022.
8:52am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: Bank of New York, Canoo, Cigna, Fiserv, Merck, Progressive, Robinhood, Wayfair and More
Friday’s top analyst upgrades and downgrades included Bank of New York Mellon, Canoo, Cigna, Fiserv, Invesco, Merck, ONEOK, Progressive, Robinhood Markets, Ross Stores and Wayfair.
8:56am ET
Investing
Monday’s Top Analyst Upgrades and Downgrades: Apple, Coca-Cola, CommScope, Coupa Software, HubSpot, Merck, NetApp, Pfizer, Shopify and More
Monday’s top analyst upgrades and downgrades included Apple, Coca-Cola, CommScope, Coupa Software, GoPro, HubSpot, Merck, NetApp, Pfizer, Shopify, Spirit Airlines and Warner Music.
8:56am ET
Investing
Tuesday’s Top Analyst Upgrades and Downgrades: Bloomin’ Brands, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Spirit Airlines, Wells Fargo and More
Tuesday’s top analyst upgrades and downgrades included Bloomin' Brands, Boston Beer, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Petco Health, Southern Company, Spirit Airlines and Wells Fargo.
9:34am ET
Investing
5 Buy-Rated Blue Chip Stocks With Dividends Expected to Rise This Week
Merck, Stryker and these other companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
8:48am ET
Investing
Monday’s Top Analyst Upgrades and Downgrades: Affirm, BlackRock, Deere, Dick’s, Dollar Tree, ICE, Mastercard, Merck, Pure Storage and More
Monday’s top analyst upgrades and downgrades included Affirm, BlackRock, Deere, Dick's Sporting Goods, Dollar Tree, Intercontinental Exchange, Mastercard, Merck, Nordstrom, Petrobras and Pure Storage.
11:28am ET
Investing
4 Buy-Rated Blue Chip Stocks With Dividend Hikes Expected This Week
McCormick, Merck and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
10:45am ET
Investing
4 Top Analyst Stock Picks With Dividend Hikes Expected This Week
Merck, Nike and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
11:45am ET
Investing
Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More
Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.
7:35am ET
Health and Healthcare
5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost structures, and they…
7:20am ET
Investing
5 Dow Stocks With the Biggest Dividends Are Great Q4 Buys Now
While the quantitative easing soon will begin to dwindle, it is highly unlikely the Federal Reserve actually will raise interest rates until 2023, so buying blue-chip stocks with solid total return potential…
7:35am ET
Investing
These 5 Dependable Dividend Stocks Are Likely to Withstand a Potential Brutal Sell-Off
The trading action late last week hints that a long-overdue market correction may be coming, so now may be the right time to take some profits and move to calmer waters. These…
8:51am ET
Investing
Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma
Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology and Vertex Pharmaceuticals.